Global GABA Receptor Agonist Drug Market Report 2024 Edition, Market Size, Share, CAGR, Forecast, Revenue

Get the sample copy of GABA Receptor Agonist Drug Market Report 2024 (Global Edition) which includes data such as Market Size, Share, Growth, CAGR, Forecast, Revenue, list of GABA Receptor Agonist Drug Companies (Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck Merck and Co, GlaxoSmithKline, NovaDel Pharma, Novartis, OVATION Pharmaceuticals, Osmotica Pharmaceutical, Pfizer, sanofi aventis, VIVUS, XenoPort), Market Segmented by Type (Bamaluzole, Phenibut, Baclofen, Gaboxadol, Klonopin (clonazepam), Tiagbine), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer, Epilepsy and Seizure, Anxiety and Sleep Disorders, Obesity and Alcoholism)

获取 2024 年全球版 GABA 受体激动剂药物市场报告样本，其中包含市场规模、份额、增长、复合年增长率、预测、收入等数据，并列举了 GABA 受体激动剂药物公司名单（Advicenne、阿斯利康、雅典药物递送解决方案、Biocodex、伊兰公司、礼来公司、H.LundBeck、默克公司、葛兰素史克、NovaDel 药业、诺华、OVATION 药物公司、Osmotica 药物公司、辉瑞、sanofi aventis、VIVUS、XenoPort），市场按类型（巴马鲁唑、苯乙醇酰胺、巴氯芬、加博唑安、氯硝西泮（氯硝西泮）、替加宾）进行细分，按应用（注意力缺陷多动障碍（ADHD）、精神疾病和抑郁症、阿尔茨海默病、癫痫和癫痫发作、焦虑和睡眠障碍、肥胖和酗酒）进行分类。